Diabetologia 57 , 129139 (2014)
High-dose Vitamin B12 May Improve ALS Prognosis if Started Early, Study Suggests Written by | Treatment with ultra-high-dose methylcobalamin, the physiologically active form of vitamin B12, may improve the prognosis of patients with amyotrophic lateral sclerosis (ALS) who receive it a year or less after symptom onset, a long-term study of Japanese reports
Your body naturally produces thousands of different peptides that coordinate inflammation resolution, wound healing, and tissue maintenance
Copper plays a role in immune regulation, and delivering it through a peptide carrier could fine-tune inflammatory responses more safely than direct metal exposure
These totals explain community planning models and are not recommendations for human use
Here is what a Las Vegas patient should understand before starting